Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention
Starting soon · Not applicable
Conditions studied: Opioid Use Disorder
In brief
The goal of this pilot trial is to develop and test a telehealth intervention for OUD care delivery and refine measurement strategies. The specific aims are to: 1) identify components of an effective telehealth intervention and barriers to implementation, 2) partner with an advisory board of OUD treatment stakeholders from different settings to develop a telehealth intervention for OUD treatment with buprenorphine, and 3) conduct a pilot trial of the telehealth intervention for OUD treatment. The investigators will enroll 60 patients, 30 individuals who are currently enrolled in in-person OUD treatment with buprenorphine, with a treatment episode duration of 1-3 months, and 30 individuals who are not currently receiving OUD treatment but approved for treatment intake at buprenorphine clinic by an OUD treatment clinician, to receive the telehealth for OUD care delivery intervention. The investigators will measure clinical, implementation, and patient satisfaction outcomes.
Key facts
- Study ID
- NCT06341608
- Run by
- University of Pennsylvania
- People needed
- 60
- Starts
- 2026-09-15
- Expected to finish
- 2028-04-01
- Last updated by the study team
- 2026-06-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- For patients:
- Must be 18 years old or older
- Clinical diagnosis of opioid use disorder and/or mental health diagnosis
- Must be receiving treatment for opioid use disorder and/or mental health diagnosis at an outpatient community-based substance use disorder and/or mental health treatment program
- Must speak English
- For providers and staff:
- Must be 18 years old or older
- Must be in a provider, clinical staff, or leadership role caring for patients with substance use disorders and/or mental health diagnoses
- Must speak English
- Aim 2b:
- Inclusion Criteria:
- Must be 18 years or older
- Clinical diagnosis of opioid use disorder
- Must be receiving treatment for OUD with buprenorphine at Prevention Point Philadelphia
- Must speak English
- Aim 3:
- Patient participants:
- Must be 18 years old or older
- Clinical diagnosis of opioid use disorder
- Must be currently receiving in-person disorder care with buprenorphine at Prevention Point for a duration of 1-3 months OR not currently receiving disorder treatment but approved for treatment intake at buprenorphine clinic by Prevention Point clinician
- Must be English speaking
- Provider and staff participants:
- Must be a provider or staff member at Prevention Point Philadelphia in the buprenorphine OUD treatment program
- Must be involved in the care of at least one patient enrolled in the pilot trial
- Must be English speaking
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.